Search results
Buyback Alert: KDDL to repurchase shares from existing shareholders at a 12% premium - CNBC TV18
CNBC TV18· 4 hours agoKDDL has regularly paid dividends to shareholders but is carrying out its first such share buyback.
The great climate change wealth transfer is here - The Economic Times
The Economic Times· 1 hour agoThanks to resilient crude prices and lacklustre investment activity, shareholders in oil and gas...
Inside Novak Djokovic's Rs 2,000 crore lavish lifestyle: From luxury homes to high-end cars and more
Indiatimes· 23 hours agoNovak Djokovic, the Serbian tennis superstar born on May 22, 1987, has carved out a place among the...
Multibagger stock Nile hits lifetime high after Dolly Khanna’s stake buying news | Stock Market News
Livemint· 24 hours agoDolly Khanna portfolio: Multibagger stock Nile is in the news these days as Chennai-based ace...
Buy or sell: Apollo Tyres to Union Bank, Vaishali Parekh recommends three stocks to buy today — July...
Livemint· 5 hours agoBuy or sell stocks: Vaishali Parekh has recommended three stocks to buy today —Latent View...
Salt Lake City takes first step toward reimagining downtown
Deseret News· 3 hours agoThe city and SEG, she said, will bring “dignity, culture, history” back to Japantown, now consisting...
Oral solid dosage manufacturing companies, equipment and market
Pharmaceutical Technology· 19 hours agoOral solid dosage manufacturing companies, equipment and market: Introduction In an industry where precision and compliance are of paramount importance, selecting the right partner for oral ...
Jammi Buildings, more than just a landmark, soon to be demolished
The Hindu· 13 hours agoJammi Buildings (yes, it was always plural) is to be demolished soon. Not just a landmark for those...
‘Eventually, they will kneel….’: Samsung Electronics workers in South Korea declare indefinite...
Livemint· 57 minutes agoThe strike is the biggest labour action in the tech giant's history and steps up pressure on the...
Pfizer research chief Dolsten to step down, with company at a crossroads
BioPharma Dive· 18 hours agoThe company has begun searching for a successor to Dolsten, who oversaw more than 35 drug and...